- Home
- RIBB vs AVTX Comparison
RIBB vs AVTX Comparison
Compare RIBB & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIBB
- AVTX
- Stock Information
- Founded
- RIBB 2024
- AVTX 2011
- Country
- RIBB Japan
- AVTX United States
- Employees
- RIBB N/A
- AVTX N/A
- Industry
- RIBB
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- RIBB
- AVTX Health Care
- Exchange
- RIBB NYSE
- AVTX Nasdaq
- Market Cap
- RIBB 64.9M
- AVTX 57.4M
- IPO Year
- RIBB 2025
- AVTX 2015
- Fundamental
- Price
- RIBB $10.15
- AVTX $4.89
- Analyst Decision
- RIBB
- AVTX Strong Buy
- Analyst Count
- RIBB 0
- AVTX 7
- Target Price
- RIBB N/A
- AVTX $31.00
- AVG Volume (30 Days)
- RIBB 11.8K
- AVTX 82.2K
- Earning Date
- RIBB 01-01-0001
- AVTX 08-11-2025
- Dividend Yield
- RIBB N/A
- AVTX N/A
- EPS Growth
- RIBB N/A
- AVTX N/A
- EPS
- RIBB N/A
- AVTX N/A
- Revenue
- RIBB N/A
- AVTX $441,000.00
- Revenue This Year
- RIBB N/A
- AVTX N/A
- Revenue Next Year
- RIBB N/A
- AVTX N/A
- P/E Ratio
- RIBB N/A
- AVTX N/A
- Revenue Growth
- RIBB N/A
- AVTX N/A
- 52 Week Low
- RIBB $9.95
- AVTX $3.39
- 52 Week High
- RIBB $10.45
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- RIBB N/A
- AVTX 54.89
- Support Level
- RIBB N/A
- AVTX $4.63
- Resistance Level
- RIBB N/A
- AVTX $5.02
- Average True Range (ATR)
- RIBB 0.00
- AVTX 0.27
- MACD
- RIBB 0.00
- AVTX 0.00
- Stochastic Oscillator
- RIBB 0.00
- AVTX 72.73
About RIBB RIBBON ACQUISITION CORP
Ribbon Acquisition Corp is a blank check company.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).